Recombinant IGF1R (960-1367) Protein
| Catalog number: | B2017591 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 g |
| Molecular Weight or Concentration: | 47 kDa |
| Supplied as: | SOLUTION |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -80C |
| Keywords: | Insulin Like Growth Factor 1 Receptor, CD221 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Klammt J, Kiess W, Pfffle R. IGF1R mutations as cause of SGA Best Pract Res Clin Endocrinol Metab. 2011 Feb;25(1):191-206.
- Di Bartolo BA, Schoppet M, Mattar MZ, Rachner TD, Shanahan CM, Kavurma MM. Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification Cardiovasc Res. 2011 Aug 1;91(3):537-45.
- Thomas SS, Wu J, Davogustto G, Holliday MW, Eckel-Mahan K, Verzola D, Garibotto G, Hu Z, Mitch WE, Taegtmeyer H. SIRP Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease Circ Res. 2022 Jul 22;131(3):207-221.
- Andersson MK, man P, Stenman G. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors Cells. 2019 Aug 16;8(8):913.
- Wang L, Wang H, Xu X, Wang D, Liu H. Insulin facilitates osteoblast differentiation Cell Biol Int. 2013 Nov;37(11):1157-61.
- Gaal OI, Liu R, Marginean D, Badii M, Cabu G, Hotea I, Nica V, Colcear D; HINT Consortium; Pamfil C, Merriman TR, Rednic S, Popp RA, Crian TO, Joosten LAB. GWAS-identified hyperuricemia-associated IGF1R variant rs6598541 has a limited role in urate mediated inflammation in human mononuclear cells Sci Rep. 2024 Feb 12;14(1):3565.
- Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS. Small round cell sarcomas Semin Oncol. 2009 Aug;36(4):338-46.
- Le Y, Chen X, Wang L, He WY, He J, Xiong QM, Wang YH, Zhang L, Zheng XQ, Wang HB. Chemotherapy-induced peripheral neuropathy is promoted by enhanced spinal insulin-like growth factor-1 levels via astrocyte-dependent mechanisms Brain Res Bull. 2021 Oct;175:205-212.
- Rapraeger AC. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-v3 integrin complex in tumorigenesis and angiogenesis FEBS J. 2013 May;280(10):2207-15.
